Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide vs. Placebo for cGVHD
NCT00003894Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Mar 1999
- Primary completion
- Jan 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in chronic graft-versus-host disease (cGVHD), sponsored by Roswell Park Comprehensive Cancer Center. Started Mar 1999; status: completed.
02
Drugs
thalidomide
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT00003894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003894.